Skip to main content

and
  1. No Access

    Article

    Prostate cancer is not just a man’s concern — the use of PSA screening in transgender women

    Transgender women remain at risk of prostate cancer and warrant consideration for PSA screening. However, current PSA reference ranges and guidelines are based on data from cisgender men. As these thresholds m...

    Farnoosh Nik-Ahd, Jennifer T. Anger, Matthew R. Cooperberg in Nature Reviews Urology (2023)

  2. No Access

    Article

    Emulation of a target trial with sustained treatment strategies: an application to prostate cancer using both inverse probability weighting and the g-formula

    As with many chronic illnesses, recurrent prostate cancer generally requires sustained treatment to prolong survival. However, initiating treatment immediately after recurrence may negatively impact quality of...

    Louisa H. Smith, Xabier García-Albéniz, June M. Chan in European Journal of Epidemiology (2022)

  3. Article

    Open Access

    Accommodating heterogeneous missing data patterns for prostate cancer risk prediction

    We compared six commonly used logistic regression methods for accommodating missing risk factor data from multiple heterogeneous cohorts, in which some cohorts do not collect some risk factors at all, and deve...

    Matthias Neumair, Michael W. Kattan in BMC Medical Research Methodology (2022)

  4. No Access

    Chapter

    Nomograms and RALP Techniques for Management of ECE: Partial Nerve Sparing

    Surgical dissection of neurovascular bundles is critical for improved functional outcomes when performing radical prostatectomy.

    Bernardo Rocco, Luca Sarchi, Tommaso Calcagnile in Robotic Urologic Surgery (2022)

  5. No Access

    Chapter

    Prostate Cancer Markers

    Diagnostic biomarkers derived from blood, urine, or prostate tissue provide additional information beyond clinical calculators to determine the risk of detecting high-grade prostate cancer. Once diagnosed, m...

    Adam J. Gadzinski, Matthew R. Cooperberg in Genitourinary Cancers (2018)

  6. Article

    Epidemiology of prostate cancer

    Matthew R. Cooperberg, June M. Chan in World Journal of Urology (2017)

  7. No Access

    Article

    Why the prostate arm of the PLCO trial failed and what it has taught us

    Given a recent update from the PLCO trial reporting that over 90% of men in the 'usual care' arm underwent some degree of PSA testing, the PLCO can no longer accurately be called a trial of screening versus no...

    Matthew R. Cooperberg in Nature Reviews Urology (2016)

  8. No Access

    Article

    Clinical Utility of Biomarkers in Localized Prostate Cancer

    A new generation of prostate cancer (PCa) biomarkers has emerged, including diagnostic serum and urine markers aimed at refining the identification high-grade tumors and tissue-based gene expression assays off...

    Michael S. Leapman, Hao G. Nguyen, Matthew R. Cooperberg in Current Oncology Reports (2016)

  9. No Access

    Article

    Long-term follow-up of International Prostate Symptom Score (IPSS) in men following prostate brachytherapy

    To investigate variation in the International Prostate Symptom Score (IPSS) in men following prostate brachytherapy.

    Xuesong Li, Dong Fang, Matthew R. Cooperberg, Jared M. Whitson in World Journal of Urology (2014)

  10. No Access

    Article

    A new look at prostate cancer treatment complications

    A recent population-based analysis from Nam and coauthors found high complication rates occurring within 5 years of prostatectomy or radiation therapy interventions for prostate cancer. These findings emphasiz...

    Matthew R. Cooperberg in Nature Reviews Clinical Oncology (2014)

  11. No Access

    Article

    Implications of the New AUA Guidelines on Prostate Cancer Detection in the U.S.

    In 2012, the U.S. Preventive Services Task Force (USPSTF) issued a blanket “D” recommendation against all prostate-specific antigen (PSA)-based early detection efforts for prostate cancer, reflecting critical ...

    Matthew R. Cooperberg in Current Urology Reports (2014)

  12. No Access

    Article

    Risk-Based Prostate Cancer Screening: Who and How?

    The purpose of this review is to identify clinical risk factors for prostate cancer and to assess the utility and limitations of our current tools for prostate cancer screening. Prostate-specific antigen is th...

    Allison S. Glass, K. Clint Cary, Matthew R. Cooperberg in Current Urology Reports (2013)

  13. No Access

    Article

    New types of radiotherapy improve cancer outcome but at what cost?

    New and very expensive forms of radiotherapy, such as intensity-modulated radiation therapy and proton therapy, have taken over the localized prostate cancer market. But is there enough evidence to justify the...

    Declan G. Murphy, Scott Williams, Matthew R. Cooperberg in Nature Reviews Urology (2012)

  14. No Access

    Article

    For localized prostate cancer, does technology equal progress?

    Recent evolution of prostate cancer treatment reflects technological arms races driven by economic incentives rather than high-quality evidence—as exemplified by proton-beam radiation, recently found markedly ...

    Matthew R. Cooperberg in Nature Reviews Clinical Oncology (2012)

  15. Article

    Open Access

    The example of CaPSURE: lessons learned from a national disease registry

    Although randomized controlled trials (RCTs) remain the gold standard for determining evidence-based clinical practices, large disease registries that enroll large numbers of patients have become paramount as ...

    Sima P. Porten, Matthew R. Cooperberg, Badrinath R. Konety in World Journal of Urology (2011)

  16. No Access

    Chapter

    Robot-Assisted Radical Prostatectomy: A Prostate Surgeon’s Perspective

    The availability and promulgation of robotic technology has resulted in a paradigm shift for radical prostatectomy. Historically radical prostatectomy was performed using an open approach, usually the retropub...

    Cole Davis, Matthew R. Cooperberg, Peter R. Carroll in Robotics in Genitourinary Surgery (2011)

  17. No Access

    Article

    Gender differences in subcutaneous and perirenal fat distribution

    Body mass index (BMI) has been shown to influence the outcome of various surgical procedures. The purpose of this study is to assess the relationship between BMI, gender, and the distribution of subcutaneous a...

    Brian H. Eisner, Javaad Zargooshi, Aaron D. Berger in Surgical and Radiologic Anatomy (2010)

  18. Article

    Open Access

    Electronic patient self-assessment and management (SAM): a novel framework for cancer survivorship

    We propose a novel framework for management of cancer survivorship: electronic patient Self-Assessment and Management (SAM). SAM is a framework for transfer of information to and from patients in such a way as...

    Andrew J Vickers, Talya Salz, Ethan Basch in BMC Medical Informatics and Decision Making (2010)

  19. No Access

    Chapter

    Quality of Care Indicators for Radical Cystectomy

    Radical cystectomy is the gold standard treatment for invasive bladder cancer, and requires high standards for both surgical skill and ancillary support to achieve consistently good outcomes. As is the case el...

    Matthew R. Cooperberg, Badrinath R. Konety in Bladder Cancer (2010)

  20. No Access

    Article

    High-risk prostate cancer in the United States, 1990–2007

    This study aimed to describe national trends in presentation, management, and outcomes for men with high risk prostate cancer.

    Matthew R. Cooperberg, Janet Cowan, Jeannette M. Broering in World Journal of Urology (2008)